Andrea S. Blevins Primeau, PhD, MBA

The risk of in-hospital death from COVID-19 for patients with cancer differs by sex and cancer type, according to a new study.

Among older patients with diabetes, metformin was associated with a reduced risk of cancer, but the combination of aspirin and metformin was associated with an increased risk of cancer death.

COVID-19 vaccines did not reduce the risk of severe COVID-19 among cancer patients who received radiation, CAR T-cell therapy, or HSCT.

Antibody testing is effective for identifying patients with cancer who have low levels of protection against SARS-CoV-2, a study suggests.